EQUILLIUM
Equillium Inc is a biotechnology company that develops products for autoimmune and inflammatory, or immuno-inflammatory disorders with an unmet medical need. Its primary product candidate is EQ001, which is a clinical-stage first-in-class monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. CD6 plays a central role in effector T cell activity, which drives a number of immuno-inflammatory diseases such as graft versus host disease, asthma, uveitis, colitis, lupus, and multiple sclerosis.
EQUILLIUM
Industry:
Biopharma Biotechnology Life Science
Founded:
2017-01-01
Address:
La Jolla, California, United States
Country:
United States
Website Url:
http://www.equilliumbio.com
Total Employee:
11+
Status:
Active
Contact:
858 412 5302
Email Addresses:
[email protected]
Total Funding:
85 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Google Universal Analytics
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with superior immune cell therapies.
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Demetrix
Demetrix is a biotechnology company dedicated to researching and producing bioactive ingredients.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-09-06 | Metacrine | Metacrine acquired by Equillium | N/A |
| 2022-02-16 | Bioniz Therapeutics | Bioniz Therapeutics acquired by Equillium | N/A |
Investors List
Decheng Capital
Decheng Capital investment in Post-IPO Equity - Equillium
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Equillium
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Equillium
Official Site Inspections
http://www.equilliumbio.com Semrush global rank: 2.05 M Semrush visits lastest month: 10.18 K
Unable to get host informations!!!
